找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Metronomic Chemotherapy; Pharmacology and Cli Guido Bocci,Giulio Francia Book 2014 The Editor(s) (if applicable) and The Author(s), under e

[復(fù)制鏈接]
查看: 22858|回復(fù): 58
樓主
發(fā)表于 2025-3-21 18:51:42 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Metronomic Chemotherapy
副標(biāo)題Pharmacology and Cli
編輯Guido Bocci,Giulio Francia
視頻videohttp://file.papertrans.cn/633/632498/632498.mp4
概述Covers all aspects of metronomic chemotherapy.Describes the pharmacological bases of metronomic chemotherapy.Presents and discusses the clinical results of all published studies on metronomic chemothe
圖書封面Titlebook: Metronomic Chemotherapy; Pharmacology and Cli Guido Bocci,Giulio Francia Book 2014 The Editor(s) (if applicable) and The Author(s), under e
描述This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic.
出版日期Book 2014
關(guān)鍵詞Antiangiogenic drugs; Cancer; Metronomic chemotherapy; Pharmacology
版次1
doihttps://doi.org/10.1007/978-3-662-43604-2
isbn_softcover978-3-662-51319-4
isbn_ebook978-3-662-43604-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag GmbH, DE
The information of publication is updating

書目名稱Metronomic Chemotherapy影響因子(影響力)




書目名稱Metronomic Chemotherapy影響因子(影響力)學(xué)科排名




書目名稱Metronomic Chemotherapy網(wǎng)絡(luò)公開度




書目名稱Metronomic Chemotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Metronomic Chemotherapy被引頻次




書目名稱Metronomic Chemotherapy被引頻次學(xué)科排名




書目名稱Metronomic Chemotherapy年度引用




書目名稱Metronomic Chemotherapy年度引用學(xué)科排名




書目名稱Metronomic Chemotherapy讀者反饋




書目名稱Metronomic Chemotherapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:17:04 | 只看該作者
Book 2014preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemot
板凳
發(fā)表于 2025-3-22 04:20:43 | 只看該作者
Development and Evolution of the Concept of Metronomic Chemotherapy: A Personal Perspectiveetronomic chemotherapy concept is summarized along with suggestions for improving its impact as a promising means of achieving better and less toxic cancer control, not only in patients in low and middle income countries, but also patients in highly developed high income countries as well.
地板
發(fā)表于 2025-3-22 06:21:44 | 只看該作者
5#
發(fā)表于 2025-3-22 09:15:00 | 只看該作者
Clinical Activity of Metronomic Chemotherapy in Central Nervous System Cancersma models and numerous clinical applications of metronomic regimens (e.g. etoposide, temozolomide) for adult patients with tumors of CNS have been described. Moreover, metronomic treatment may serve as a useful platform for combination strategies in certain CNS tumors.
6#
發(fā)表于 2025-3-22 16:04:28 | 只看該作者
7#
發(fā)表于 2025-3-22 20:59:37 | 只看該作者
Metronomic Chemotherapy in Pediatric Malignanciesatriccancer. Maintenancelowdosechemotherapyhasproven itsbenefits in increasingoverallsurvival inseveral pediatric cancer. Thischapter isreviewingthecurrentknowledge ofpediatric metronomic chemotherapy and potential forfuture development ascytotoxic agents or in combinationwith targetedtherapy including its potentialapplicationinemergingcountries.
8#
發(fā)表于 2025-3-22 22:13:58 | 只看該作者
9#
發(fā)表于 2025-3-23 02:13:22 | 只看該作者
Preclinical Activity of Metronomic Regimens with Alkylating Agents and Antimetabolitesnomic chemotherapy approach. Much of this report concerns cyclophosphamide, since, in this context, it is the most widely explored drug so far. The report also draws attention to the numerous cancer cell lines and the main murine models used.
10#
發(fā)表于 2025-3-23 08:16:28 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 17:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
四平市| 鲜城| 金川县| 萨嘎县| 建水县| 莆田市| 温宿县| 象州县| 龙井市| 荣成市| 青阳县| 兰考县| 连城县| 太仆寺旗| 合作市| 岫岩| 南充市| 北川| 格尔木市| 大安市| 河北区| 扶风县| 筠连县| 南充市| 印江| 上蔡县| 溧阳市| 红桥区| 莱西市| 永年县| 沙坪坝区| 丰都县| 平定县| 夹江县| 南陵县| 交口县| 广南县| 新密市| 霍城县| 长沙市| 峨山|